Oracle's Analyst Day Unveils Strategy, Weight Of Cloud For Goldman Sachs Analysts
Close on heels of Oracle Corporation (NYSE: ORCL)'s analyst day, which Goldman Sachs attended, and the firm's panel discussions with four Oracle Platinum Partners and cloud infrastructure vendors, the brokerage delved on the highlights and takeaways from these events.
Analyst Heather Bellini noted that the analyst day was focused on its cloud strategy on SaaS, PaaS and laaS along with some new product/strategy announcements. The analyst said she deduced the company is serious about PaaS/laaS, as the management highlighted the advantages of its new generation 2 data centers in terms of cost, security and reliability.
The firm also noted that Oracle took the fight to Amazon.com, Inc. (NASDAQ: AMZN)'s camp by delving on the value proposition of its data centers relative to Amazon AWS.
Bellini also expressed pleasure regarding Oracle's new program to reduce friction in selling process and its message that it is expanding down market.
Goldman's panel sessions revealed that Oracle's full suite of apps is a differentiator, helping it to win deals and that the company is facing less competition in cloud ERP versus other SaaS categories. The partners, according to the firm, are committed to Oracle's PaaS and laaS offerings.
Goldman also noted that cloud infrastructure vendors such as Docker and Mesosphere were unsure what role server software vendors like Microsoft Corporation (NASDAQ: MSFT), VMware, Inc. (NYSE: VMW) and Red Hat Inc (NYSE: RHT) will play in public cloud.
At time of writing, Oracle was down 0.78 percent on Friday, trading at $39.20. Goldman Sachs has a Buy rating and 12-month price target of $47 on the shares.
Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email email@example.com with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!
Latest Ratings for ORCL
|Jan 2017||Wells Fargo||Initiates Coverage On||Outperform|
|Sep 2016||RBC Capital||Maintains||Outperform|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.